Back to Studies

P1086 / Phase II Study in HIV Positive Pregnant Women to Assess the Safety and Immunogen

A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 Infected Pregnant Women

Study Status

Concluded

DAIDS Number

10835

IND Number

BB 14147

Summary

P1086 was a multi-center, Phase II, open label study of an inactivated Influenza A (H1N1) 2009 monovalent vaccine.  The study was designed to determine the safety and antibody response after each of two doses of Influenza A (H1N1) 2009 Monovalent Vaccine in HIV-1 infected pregnant women.

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...